PreClinOmics, Inc.
P. O. Box 68845 7918 Zionsville Road
Indianapolis, Indiana 46268
Phone 317.872.6001
Fax 317.872.6002
 |
PreClinOmics, Inc.P. O. Box 68845 7918 Zionsville Road |
|
PreClinOmics™ (PCO) is a Contract Research and Service Company dedicated to providing high quality in vivo, preclinical laboratory services for the Pharmaceutical and Biotech industry, as either a primary or a study validation source. PCO currently specializes in metabolic disease disorders including diabetes, hypertension, hyperlipidemia, heart failure, obesity and renal failure.
J. F. (Joe) Pesek
Chairman and CEO
Richard G. Peterson, PhD
Director of Research
Terence T. Yen, PhD
Consultant and Principal Investigator
PCO was formed in July 2001 by the same management team and advisors who established Genetic Models Inc. in 1991. Genetic Models (Gmi) brought to the scientific research community such animal models as the ZDF, SHHF, and ZSF1, which proved to be excellent research subjects for the study of the etiology of diabetes, hypertension, heart failure, hyperlipidemia and kidney failure, and for the demonstration of efficacy and mechanism of compounds in these disorders. Building upon the small division of Gmi that performed research and demonstrated compound efficacy for some of its customers, Joe Pesek and Richard Peterson, in collaboration with an internationally respected team of scientific advisors, founded PreClinOmics. The company currently specializes in complex disease disorders such as diabetes, hypertension, heart and renal failure and obesity, as either a primary study or validation source for compounds used in the treatment of these disorders. PCO is currently expanding their capabilities to include experimental protocols geared to the study of solid tumor cancers.
PCO recently increased its staff of highly skilled technicians and, in concert with project consultants, aims to provide services with a "zero defect" standard of excellence in a highly responsive time frame. As a relatively small company, project costs remain competitive. Studies can be conducted according to Good Laboratory Practice (GLP) standards, as though PCO facilities are an extension of the sponsor's lab. The company is actively pursuing AAALAC and GLP accreditation.